USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark VENOGLOBULIN was filed as Word mark on 03/01/2001 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 05/20/2003.
The current status of the mark is "CANCELLED - SECTION 8".
| Trademark form | Word mark |
| File reference | 76217836 |
| Register number | 2717023 |
| Application date | March 1, 2001 |
| Publication date | February 25, 2003 |
| Entry date | May 20, 2003 |
Trademark owner
Chuo-ku, Osaka-shi
Osaka 541-0046
JP
Osaka 541-0046
JP
Trademark representatives
goods and services
5
Pharmaceutical preparations in the nature of gammaglobulin preparations for use in the treatment of primary immunodeficiencies, immune-mediated thrombocytopenia, Kawasaki syndrome, recent bone marrow transplant in adults, chronic B-cell lymphocytic leukemia, pediatric HIV infection, chronic inflammatory demyelinating polyneuropathy, post-transfusion purpura, Guillain-Barre syndrome and chronic inflammatory demyelinating polyneurophathy, anemia because of parvovirus B19, patients with stable multiple myeloma who are at high risk for recurrent infection, cytomegalovirus (CMV)-negative recipients of CMV-positive organs, hypogammaglobulinemic neonates with risk factor for infection or morbidity, intractable epilepsy, systemic vasculitic syndromes, warm-type automimmune hemolytic anemia, neonatal alloimmune thrombocytopenia when unresponsive to other treatments, immune-mediated neutropenia, decompensation in myasthenia gravis, dermatomyositis, polymyosits, thrombocytopenia when severe and unresponsive to other treatments
ID: 1376217836